Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
Bespak – 21.05.2025
Stoelzle – 15th May 2025

What Does the Falsified Medicines Directive (FMD) Mean for SMEs and CMOs; and More Importantly, Are These Organisations Ready?

The implications of the directive are far-reaching and affect
all pharmaceutical manufacturers, regardless of size. As
time runs out and the deadline grows ever closer, Christian
Taylor of Zetes explains in his article how CMOs and
SME pharmaceutical manufacturers can ensure they are
compliant. If smaller organisations embrace the regulatory
changes – using them as an opportunity to optimise their
supply chains, they can create true business value, making
it pay to be compliant.

Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025